Key Immune Cells Predict Recurrence in Lung Cancer Patients
December 27th, 2006
Patients treated surgically for early-stage lung cancer face an increased risk of recurrence if their tumors contain a large number of cells that act as “dimmer switches” on the immune system, according to a study at Duke University Medical Center.